Control Bionics Ltd. (AU:CBL) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Control Bionics Ltd has successfully raised $310,000 through the issuance of shortfall shares from its Non-Renounceable Rights Issue, resulting in 4.428 million shares and 2.214 million options. The placement was facilitated by Lynx Advisors, which received 650,000 options for arranging the transaction. This strategic move underscores Control Bionics’ commitment to advancing its innovative medical devices.
For further insights into AU:CBL stock, check out TipRanks’ Stock Analysis page.